Gables Capital Management’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.88M | Sell |
|
|||||
|
2025
Q1 | $10.1M | Sell |
|
|||||
|
2024
Q4 | $8.71M | Sell |
|
|||||
|
2024
Q3 | $8.49M | Sell |
|
|||||
|
2024
Q2 | $6.69M | Sell |
|
|||||
|
2024
Q1 | $6.96M | Buy |
|
|||||
|
2023
Q4 | $7.3M | Buy |
|
|||||
|
2023
Q3 | $5.05M | Sell |
|
|||||
|
2023
Q2 | $5.85M | Buy |
|
|||||
|
2023
Q1 | $6.78M | Sell |
|
|||||
|
2022
Q4 | $7.86M | Sell |
|
|||||
|
2022
Q3 | $5.57M | Sell |
|
|||||
|
2022
Q2 | $3.06M | Sell |
|
|||||
|
2022
Q1 | $3.64M | Sell |
|
|||||
|
2021
Q4 | $3.04M | Buy |
|
|||||
|
2021
Q3 | $2.08M | Buy |
|
|||||
|
2021
Q2 | $1.97M | Sell |
|
|||||
|
2021
Q1 | $1.88M | Sell |
|
|||||
|
2020
Q4 | $1.38M | Sell |
|
|||||
|
2020
Q3 | $1.29M | Sell |
|
|||||
|
2020
Q2 | $2.34M | Sell |
|
|||||
|
2020
Q1 | $1.98M | Sell |
|
|||||
|
2019
Q4 | $1.94M | Buy |
|
|||||
|
2019
Q3 | $2.61M | Buy |
|
|||||
|
2019
Q2 | $1.87M | Buy |
|
|||||
|
2019
Q1 | $2.45M | Sell |
|
|||||
|
2018
Q4 | $923K | Buy |
|
|||||
|
2018
Q3 | $1.69M | Buy |
|
|||||
|
2018
Q2 | $1.51M | Sell |
|
|||||
|
2018
Q1 | $1.1M | Buy |
|